Deschenes Roger P. 4
4 · IMPLANT SCIENCES CORP · Filed Nov 30, 2012
Insider Transaction Report
Form 4
IMPLANT SCIENCES CORPOTCBB:IMSC
Deschenes Roger P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2012-11-28$0.10/sh+100,000$10,000→ 200,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-11-28−100,000→ 0 totalExercise: $0.10Exp: 2019-06-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These options are exercisable in three equal annual installments commencing June 30, 2010.